AGP Executive Report
Last update: 6 hours agoMedicine Access & Pricing: Bulgaria is moving to protect generic medicines supply by scrapping mandatory rebates for generic manufacturers after a record wave of medicine withdrawals in 2025, leaving thousands struggling to get treatments. Public Health Safety: The NHS warns people taking amitriptyline about a rare but serious side effect—sudden eye pain with vision changes, swelling, or redness—requiring urgent medical advice. Ancient Medical Discovery: Archaeologists at Heraclea Sintica uncovered an exceptionally rare Roman surgical tool used to remove bladder stones, pointing to advanced medical practice in the region. Heat & Wellbeing Context: Reports highlight how extreme heat is hitting Europe again, with major differences in how well countries are prepared—an issue that directly affects health and daily safety. Healthcare Leadership: Bulgaria has elected a new deputy head at the National Health Insurance Fund, as the system continues to reorganize amid budget and policy pressure. Local Health Infrastructure: Sofia’s draft budget debate includes concerns about missing or unstable funding for key public services, including major healthcare-related needs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Bulgaria moves to shore up generic medicines access amid shortage crisis [Advocacy Lab]](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/26425177-924635355-GettyImages-2214872699-100x67.jpeg)
